Skip to main content
Caplight Logo









Inside Therapeutics

Inside Therapeutics

Private
AngoulêmeHealthcare & Life Scienceshttps://insidetx.com/

Last Round

VC Round

Jun 3, 2025

Total Funding Raised

$2.86M

Company Overview

Inside Therapeutics is a biotechnology company that designs, develops, and markets microfluidic-based instruments for the formulation and manufacturing of lipid nanoparticles and RNA-LNP therapeutics.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

microfluidicslipid nanoparticlesLNPnanomedicine manufacturingRNA encapsulationdrug delivery techbiotech equipmentnanoparticle formulationlab automationRNA therapeuticsmicrofluidic chipspreclinical R&Ddrug discovery toolsbenchtop manufacturingfluidics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Inside Therapeutics Comparables

Compare Inside Therapeutics with similar companies based on industry and business-model similarity.

Inside Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
DIANT Pharma Inc.
80%
纳智达(上海)纳米技术有限公司
79%
KNAUER Wissenschaftliche Geräte GmbH
78%

Inside Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJun 3, 2025
GrantMay 21, 2025
SeedJun 20, 2024

Key People

Founding team and executive leadership

Thomas Guerinier

Chief Executive Officer

Executive Team

Matthieu KERHUEL

Chief Technology Officer

Executive Team

Hélène Beaupied

Chief Operating Officer

Executive Team

Inside Therapeutics Investors

Notable investors and investment history

Inside Therapeutics investors
InvestorRounds
Aquiti GestionVC Round
Newfund NAEH InnopySeed, VC Round
BpifranceGrant
SkaleParkSeed, VC Round
Région Pays de la LoireGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 21, 2025

    $1.47M grant received from Bpifrance and Région Pays de la Loire.

  • Aug 30, 2024

    Grew 30% QoQ, from 10 to 13 employees.

Inside Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Inside Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Inside Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersAngoulême
Employee Range18
Year Founded2022
Last FundingJun 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?